katrina4384Jun 120 min readDuring HD Awareness Month, Teva Announces News About Single Tablet, Once a Day Austedo XR!HD Community Letter.pdfDownload PDF • 215KB
Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington’s Disease
Interim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects at Month 12 in Huntington's Disease Patients
